Also indexed as: Wheat Germ Oil (Octacosanol)
What does it do? Octacosanol is a waxy substance naturally
present in some plant oils and is the primary component of sugar cane extract called
policosanol.
Octacosanol-containing wheat germ oil has been investigated long ago as an ergogenic (exercise performance–promoting) agent.
These preliminary studies found that octacosanol had promising effects on endurance, reaction
time, and other measures of exercise capacity.1 In another trial, 1,000 mcg per day
of octacosanol for eight weeks was found to improve grip strength and visual reaction time,
but it had no effect on chest strength, auditory reaction time, or endurance.2
Where is it found? Octacosanol is a waxy substance found in
vegetable oils and sugar cane (Saccharum officinarum). Another compound, called
policosanol, contains a large amount of octacosanol, along with several similar compounds.
Octacosanol has been used
in connection with the following conditions (refer to the individual
health concern for complete information):
Who is likely to be deficient? Because octacosanol is not an
essential bodily constituent, deficiencies do not occur.
How much is usually taken? When octacosanol is taken as part
of policosanol, 5–10 mg of policosanol is taken twice each day with meals. For exercise
performance, 1 mg per day of octacosanol has been used.
Are there any side effects or interactions? Long-term trials
in humans using amounts up to 20 mg per day have not shown any negative
effects.3
At the time of writing, there were no well-known drug interactions
with octacosanol.
References:
1. Cureton TK. The physiological effects of wheat germ oil on humans. In
Exercise. Illinois: Charles C Thomas, 1972, 296–300.
2. Saint-John M, McNaughton L. Octacosanol ingestion and its effects on
metabolic responses to submaximal cycle ergometry, reaction time and chest and grip strength.
Int Clin Nutr Rev 1986;6(2):81–7.
3. Pons P, Rodriguez M, Robaina C, et al. Effects of successive dose
increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia
and tolerability to treatment. Int J Clin Pharm Res 1994;14:27–33.
Copyright © 2002 Healthnotes, Inc. All rights reserved.
www.healthnotes.com
Learn more about Healthnotes, the company.
Learn more about the authors of Healthnotes.
The information presented in Healthnotes is for informational
purposes only. It is based on scientific studies (human, animal, or in vitro),
clinical experience, or traditional usage as cited in each article. The results reported may
not necessarily occur in all individuals. For many of the conditions discussed, treatment with
prescription or over-the-counter medication is also available. Consult your doctor,
practitioner, and/or pharmacist for any health problem and before using any supplements or
before making any changes in prescribed medications. Information expires December 2003.
|